Nick Wykeman Insider Profile
4 Followers
Nick Wykeman, Chief Financial Officer at Allergy Therapeutics, holds 300.00K shares in Allergy Therapeutics (Ticker: GB:AGY). Most recently, Nick Wykeman Bought 150,000 shares of Allergy Therapeutics on Oct 24, 2018 for an estimated value of 26.25K .
Nick Wykeman's Trading History
| AGYAllergy Therapeutics | Oct 24, 2018 | Chief Financial Officer | Informative Buy | 26.25K | £4.35K | ||||||||||||||||||||||
GB:AGY Insider Shares: 300.00K (4.72%)
| |||||||||||||||||||||||||||
You May Also Like
Nick Wykeman insider profile FAQ
What is the percentage of profitable transactions made by Nick Wykeman?
The percentage of profitable transactions made by Nick Wykeman is 50%.
What is the average return per transaction made by Nick Wykeman?
The average return per transaction made by Nick Wykeman is 18.10%.
What stocks does Nick Wykeman hold?
Nick Wykeman holds: GB:AGY stocks.
What was Nick Wykeman’s latest transaction?
Nick Wykeman’s latest transaction was an Informative Buy of 26.25K .
What was Nick Wykeman's most profitable transaction?
Nick Wykeman’s most profitable transaction was an Informative Buy of GB:AGY stock on September 28, 2016. The return on the trade was 70.10%.
What is Nick Wykeman's role in Allergy Therapeutics?
Nick Wykeman's role in Allergy Therapeutics is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
